Table 2.
Association Analysis of RNF213 SNPs Other Than the p.R4810K Variant
Variant | dbSNP138 rs-ID | At-Risk Allele | MMD 11/12/22 (RAF) | Control 11/12/22 (RAF) | P Value | Odds Ratio [95% CI] | Conditional P Value |
---|---|---|---|---|---|---|---|
p.Pro61Leu | rs9913317 | Pro | 95/8/0 (0.961) | 171/10/3 (0.956) | 0.81 | 1.10 [0.50 to 2.42] | 0.61 |
p.Met270Thr | rs17857135 | Met | 98/5/0 (0.975) | 147/36/1 (0.896) | 0.0013 | 4.86 [1.85 to 12.7] | 0.059 |
p.Met321Thr | rs17853989 | Met | 98/5/0 (0.975) | 148/36/0 (0.902) | 0.0016 | 4.76 [1.80 to 12.5] | 0.065 |
p.Pro729Leu | rs72849841 | Pro | 103/0/0 (1.00) | 179/5/0 (0.986) | 1.0 | NA | 1.0 |
p.Ala1041Thr | rs61359568 | Ala | 103/0/0 (1.00) | 169/14/1 (0.956) | 1.0 | NA | 1.0 |
p.Gln1133Lys | rs8082521 | Gln | 80/21/2 (0.878) | 111/60/13 (0.766) | 0.0023 | 2.09 [1.30 to 3.37] | 0.98 |
p.Val1195Met | rs10782008 | Val | 71/29/3 (0.830) | 89/74/21 (0.684) | 0.00035 | 2.16 [1.41 to 3.31] | 0.31 |
p.Glu1272Gln | rs9913636 | Glu | 70/30/3 (0.825) | 100/71/13 (0.736) | 0.017 | 1.68 [1.09 to 2.6] | 0.77 |
p.Asp1331Gly | rs8074015 | Asp | 69/29/5 (0.810) | 78/83/23 (0.649) | 0.00011 | 2.26 [1.49 to 3.41] | 0.34 |
p.Ser2334Asn | rs9674961 | Ser | 71/30/2 (0.835) | 79/79/26 (0.644) | 0.0000062 | 2.71 [1.76 to 4.18] | 0.12 |
p.Asp2554Glu | rs138516230 | Asp | 103/0/0 (1.00) | 174/9/1 (0.970) | 1.0 | NA | 1.0 |
p.Cys3008Arg | rs61600413 | Cys | 101/2/0 (0.990) | 171/13/0 (0.964) | 0.081 | 3.83 [0.84 to 17.3] | 0.54 |
p.Ala3468Val | rs142798005 | Ala | 101/2/0 (0.990) | 180/4/0 (0.989) | 0.90 | 1.12 [0.20 to 6.23] | 0.61 |
p.Val3838Leu | rs35332090 | Val | 101/2/0 (0.990) | 153/29/2 (0.910) | 0.0020 | 9.71 [2.29 to 41.1] | 0.10 |
p.Gly3915Glu | rs61740658 | Gly | 101/2/0 (0.990) | 157/25/2 (0.921) | 0.0043 | 8.21 [1.93 to 34.8] | 0.14 |
p.Ala4399Thr | rs148731719 | Thr | 0/14/89 (0.067) | 1/20/159 (0.061) | 0.75 | 1.12 [0.55 to 2.25] | 0.063 |
Allele 1 and 2 represent at-risk allele and other allele, respectively; 11, homozygous genotype for allele 1; 12, heterozygous genotype; 22, homozygous genotype for allele 2. MMD indicates Moyamoya disease; NA, not applicable; RAF, risk allele frequency; SNPs, single-nucleotide polymorphisms.